Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Change in Account Payables: 2012-2024

Historic Change in Account Payables for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to -$318,000.

  • Ocular Therapeutix's Change in Account Payables fell 528.28% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $578,000, marking a year-over-year increase of 155.75%. This contributed to the annual value of -$318,000 for FY2024, which is 154.55% down from last year.
  • Ocular Therapeutix's Change in Account Payables amounted to -$318,000 in FY2024, which was down 154.55% from $583,000 recorded in FY2023.
  • Ocular Therapeutix's 5-year Change in Account Payables high stood at $1.8 million for FY2021, and its period low was -$621,000 during FY2022.
  • For the 3-year period, Ocular Therapeutix's Change in Account Payables averaged around -$118,667, with its median value being -$318,000 (2024).
  • Per our database at Business Quant, Ocular Therapeutix's Change in Account Payables slumped by 464.52% in 2020 and then skyrocketed by 497.35% in 2021.
  • Yearly analysis of 5 years shows Ocular Therapeutix's Change in Account Payables stood at -$452,000 in 2020, then surged by 497.35% to $1.8 million in 2021, then plummeted by 134.58% to -$621,000 in 2022, then soared by 193.88% to $583,000 in 2023, then crashed by 154.55% to -$318,000 in 2024.